Congratulations to our clients in Japan on their February publication in Nature Medicine!

Dr. Keizo Nishikawa and team identified various metabolic processes involved in osteoclastogenesis, including the increased production of SAM. The research provides knowledge towards developing new therapeutic strategies for a variety of bone disorders.

Mediomics’ Bridge-It S-adenosyl Methionine Assay Kit was used in the study to detect SAM in osteoclast precursors and osteoclasts.

Mediomics is proud to serve such innovative clients and wishes them the best of luck in their future projects!

To read more about Dr. Nishikawa’s research, access the link here.